Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine for Hemodynamic Changes in Bariatric Surgery
NCT07054138Completed
- Sponsor
- Tanta University
- Start
- Jul 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Tanta University. Primary endpoint: Incidence of increase in hemodynamic response. Started Jul 2025; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT07054138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07054138.